Skip to main content
. 2022 Mar 4;83(2):231–238. doi: 10.15288/jsad.2022.83.231

Table 4.

Cost-effectiveness results for brief intervention

graphic file with name jsad.2022.83.231tbl4.jpg

Model Marginal cost of screening and brief intervention for patients with a positive screen for brief intervention (SE)a Percentage of patients with a positive screen for brief intervention who received brief intervention Incremental cost-effectiveness ratio
Generalist $6.05 37.7% (5.6%) -
Specialist $6.72 7.2% (2.9%) Economically dominated
a

Costs are in 2017 U.S. dollars.